Skip to content

Effects of acetaminophen mannitol injection on acute pain and levels of inflammatory mediators in patients undergoing thoracoscopic wedge-shaped lung resection

Effects of acetaminophen mannitol injection on acute pain and levels of inflammatory mediators in patients undergoing thoracoscopic wedge-shaped lung resection

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094327
Enrollment
Unknown
Registered
2024-12-20
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary nodule

Interventions

Acetaminophen mannitol injection group:Acetaminophen mannitol injection was injected intravenously 15 minutes before the operation began and 15 minutes after the injection was completed
Normal saline group:Normal saline was injected intravenously 15 minutes before the operation and 15 minutes after the infusion

Sponsors

Chengdu Jinniu District People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Age =18 years old, gender unlimited; 2) ASA I-II level; 3) Patients who plan to undergo elective thoracoscopic pulmonary resection under bronchial intubation general anesthesia; 4) Sign informed consent voluntarily.

Exclusion criteria

Exclusion criteria: 1) History of allergy to acetaminophen; 2) A known or suspected history of opioid intolerance; 3) A history of chronic pain or use of opioids or other pain modulators within the previous 2 weeks; 4) End-stage renal disease; 5) End-stage liver disease; 6) Severe depression or anxiety; 7) Seizures; 8) Known or suspected history of alcohol or drug abuse.

Design outcomes

Primary

MeasureTime frame
Total dosage of sufentanil within 24 h after first administration;NRS scores during exercise 24 hours after surgery;TNF-a;CRP;IL-6;

Secondary

MeasureTime frame
Intraoperative adverse reactions;Postoperative related complications;

Countries

China

Contacts

Public ContactZhu Li

Chengdu Jinniu District People's Hospital

353144776@qq.com+86 182 0028 5020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026